£1m grant for Bristol chemists
8 Jun 2016 by Evoluted New Media
Bristol University chemists have been awarded £930,000 to develop new smoking cessation aids.
Bristol University chemists have been awarded £930,000 to develop new smoking cessation aids.
The grant, from the Engineering and Physical Sciences Research Council (EPSRC), will allow researchers to use synthetic chemistry, computational modelling, pharmacology and structural biology to create the smoking cessation aids.
Professor Adrian Mulholland, from the University’s School of Chemistry, said: “This project will explore promising new compounds for smoking cessation. We will work directly with industrial partners who will provide expertise and testing. This provides a direct route to developing new smoking cessation therapies and bringing these new discoveries to market.”
There are more than one billion smokers worldwide, with half of them likely to die from a smoking related disease if they do not quit. Smoking has been estimated to cost the NHS two billion pounds every year, according to Action on Smoking and Health.
The project, Nicotinic Ligand Development to Target Smoking Cessation and Gain a Molecular Level Understanding of Partial Agonism, will run for three years. Extab Corporation is listed as project partners on the ESPRC grant information.
